Lack of tocilizumab effect on mortality in COVID19 patients

Off-label tocilizumab use in COVID-19 patients reflects concern for cytokine release syndrome. Comparison of matched COVID-19 pneumonia patients found elevated IL-6 levels correlated with mortality that did not change with tocilizumab administration. Correlating mortality with increased IL-6 doesn’t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Holt, Gregory E., Batra, Mayank, Murthi, Mukunthan, Kambali, Shweta, Santos, Kayo, Bastidas, Maria Virginia Perez, Asif, Huda, Haddadi, Sara, Arias, Sixto, Mirsaeidi, Mehdi
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7555891/
https://ncbi.nlm.nih.gov/pubmed/33051534
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-74328-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados